The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
| Image |  |
|---|---|
| Description | scientific article published on 22 November 2018 |
| Author/s |
author: Daniel Duerschmied John H. Alexander John J. P. Kastelein Christoph Bode |
| Publication date | November 22, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |